The innate ligand of TfR1 (CD71) is human HFn through binding to the BC loop of HFn [36, 41], which is the primary reason why we chose to fabricate recombinant HFn for a glioma-targeting drug delivery system. Here, TFRC is linked to central nervous system cancer.